Literature DB >> 30712120

Clinical and radiological findings in Brazilian patients with mucolipidosis types II/III.

José Ricardo Magliocco Ceroni1, Gustavo Marquezani Spolador2, Diana Salazar Bermeo2, Rachel Sayuri Honjo2, Luiz Antonio Nunes de Oliveira3, Débora Romeo Bertola2,4, Chong Ae Kim2.   

Abstract

OBJECTIVE: The present study aims to provide orientation for clinicians and radiologists to recognize the most prevalent findings leading to diagnosis in mucolipidosis from a description of the natural history of five Brazilian cases.
MATERIALS AND METHODS: We conducted an observational and retrospective study of five patients with clinical and radiological diagnosis of mucolipidosis. Clinical evaluation consisted of information obtained from records and including physical, neurologic, and dysmorphic evaluations. Radiologic studies consisted of complete skeletal radiographs of all patients. Enzyme assessment was performed for confirmation of the diagnosis.
RESULTS: The five patients were referred for genetic evaluation due to disproportionate short stature with short trunk accompanied by waddling gait. Age at referral varied from 11 months to 28 years. The most prevalent findings were joint restriction (4/5 patients), neuropsychomotor developmental delay (3/5), coarse facies (2/5), hypertrophic cardiomyopathy (2/5), and mental retardation (1/4 patients). The most common radiological findings were anterior beaking of the vertebral bodies (5/5), shallow acetabular fossae (5/5), epiphyseal dysplasia (5/5), platyspondyly (4/5), pelvic dysplasia (4/5), decreased bone mineralization (4/5), scoliosis (3/5), wide and oar-shaped ribs (3/5), generalized epiphyseal ossification delay (3/5), and hypoplasia of basilar portions of ilea (3/5). Enzyme assessment showed α-iduronidase, α-mannosidase, β-glucuronidase, hexosaminidase A, and total hexosaminidase increased in plasma and normal glycosaminoglycans concentration. One patient was clinically classified as ML II and four patients as ML III.
CONCLUSIONS: The follow-up of five patients showed the typical clinical and radiological findings allowing the diagnosis, thus improving clinical management and providing adequate genetic counseling. Clinicians and radiologists can take advantage of the information from this work, enhancing their differential diagnosis ability.

Entities:  

Keywords:  Dysostosis multiplex; I-cell disease; Lysosomal storage disease; Mucolipidosis II; Mucolipidosis III; Skeletal dysplasia

Mesh:

Year:  2019        PMID: 30712120     DOI: 10.1007/s00256-019-3159-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  6 in total

1.  I-cell disease: biochemical studies.

Authors:  J G Leroy; M W Ho; M C MacBrinn; K Zielke; J Jacob; J S O'Brien
Journal:  Pediatr Res       Date:  1972-10       Impact factor: 3.756

2.  [Hurler's pseudo-polydystrophy].

Authors:  P Maroteaux; M Lamy
Journal:  Presse Med       Date:  1966-12-25       Impact factor: 1.228

3.  The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment.

Authors:  C Robinson; N Baker; J Noble; A King; G David; D Sillence; P Hofman; T Cundy
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

4.  I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis.

Authors:  Ankur Singh; Rajniti Prasad; Aditya Kumar Gupta; Anil Sharma; Sandra Alves; Maria Francisca Coutinho; Seema Kapoor; Om Prakash Mishra
Journal:  Indian J Pediatr       Date:  2016-10-27       Impact factor: 1.967

5.  Early characteristic radiographic changes in mucolipidosis II.

Authors:  Lillian M Lai; Ralph S Lachman
Journal:  Pediatr Radiol       Date:  2016-08-15

6.  Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II.

Authors:  Katrin Kollmann; Jan Malte Pestka; Sonja Christin Kühn; Elisabeth Schöne; Michaela Schweizer; Kathrin Karkmann; Takanobu Otomo; Philip Catala-Lehnen; Antonio Virgilio Failla; Robert Percy Marshall; Matthias Krause; Rene Santer; Michael Amling; Thomas Braulke; Thorsten Schinke
Journal:  EMBO Mol Med       Date:  2013-10-15       Impact factor: 12.137

  6 in total
  2 in total

1.  Clinical Characterization of Mucolipidoses II and III: A Multicenter Study.

Authors:  Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Erlane M Ribeiro; Charles M Lourenço; Chong Ae Kim; Eugênia R Valadares; Marcial Francis Galera; Angelina X Acosta; Dafne Dain Gandelman Horovitz; Ida Vanessa Doederlein Schwartz
Journal:  J Pediatr Genet       Date:  2019-09-24

2.  Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis).

Authors:  Shao-Jia Mao; Yu-Mei Zu; Yang-Li Dai; Chao-Chun Zou
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.